ReviewCureus2023
Clinical Outcomes of Polymer-Free Versus Polymer-Coated Drug-Eluting Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 26 citations in OpenAlex.
- Safety, efficacy, OCT-assessed vascular healing and angiographic outcomes of polymer-free versus biodegradable-polymer drug-eluting stents in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.European journal of medical research · 2026Review
- Risk stratification and management of arrhythmias in patients with Wolff-Parkinson-White syndrome.Annals of medicine and surgery (2012) · 2025Review
- The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review.Annals of medicine and surgery (2012) · 2025Review
- The combination effect of treadmill exercise and valerian hydroalcoholic extract on the heart of type 2 diabetic rats.Annals of medicine and surgery (2012) · 2025Article
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023.Annals of medicine and surgery (2012) · 2024Review
- Fractional flow reserve versus intravascular ultrasound during percutaneous intervention.Annals of medicine and surgery (2012) · 2024Article
- Intestinal microbiome as a diagnostic marker of coronary artery disease: a systematic review and meta-analysis.Annals of medicine and surgery (2012) · 2024Review
- Coatings for Cardiovascular Stents-An Up-to-Date Review.International journal of molecular sciences · 2024Review
- Diffuse arterial atherosclerosis presenting with acute ischemic gastritis: A case report.World journal of clinical cases · 2023Article
- Review
- Challenges and Opportunities in Developing Tailored Pain Management Strategies for Liver Patients.Cureus · 2023Review
- Insulin Resistance and Coronary Artery Disease: Untangling the Web of Endocrine-Cardiac Connections.Cureus · 2023Review
- Lipid Disorders and Cardiovascular Risk: A Comprehensive Analysis of Current Perspectives.Cureus · 2023Review
- Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies.Cureus · 2023Review
- Review
- Review
- Holistic Approaches to Arrhythmia Management: Combining Medication, Ablation, and Device Interventions.Cureus · 2023Review
- Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways.Cureus · 2023Review
- Review
- Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors.Cureus · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 12 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-eluting stents have transformed the treatment of coronary artery disease (CAD), and there are two types: polymer-free and polymer-coated stents. Polymer-free stents have a coating that is quickly absorbed by the body, whereas polymer-coated stents have a coating that remains on the stent surface. This meta-analysis and systematic review aimed to compare the clinical outcomes of these two stent types in patients with coronary artery disease. The literature and abstracts from significant databases were reviewed to compare polymer-free drug-eluting stents (PF-DES) and polymer-coated drug-eluting stents (PC-DES) for the treatment of coronary artery disease (CAD). The primary efficacy endpoints of the study were all-cause mortality and deaths from cardiovascular and non-cardiovascular causes. Among the secondary outcomes were incidences of myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), stent thrombosis, stroke, and major adverse cardiovascular events (MACEs). In terms of the primary outcomes, the combined analysis revealed a marginally lower risk of all-cause mortality (relative risk, RR (95% CI) = 0.92 (0.85, 1.00), p = 0.05, I
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.